Research and development Driving scientific innovation to deliver the next generation of transformational medicines and vaccines for patients
Read morePress releases
- Nucala (mepolizumab) is the first treatment to show a significant reduction in flares for patients with Hypereosinophilic Syndrome (HES)
- EACS 2019: ViiV Healthcare to present 17 abstracts from its portfolio addressing the diverse needs of people living with HIV
- GSK delivers sales of £9.4 billion +16% AER, +11% CER (Pro-forma +6% CER*)
Tweets from GSK
-
GSK @GSK
“The most important thing that's helped at GSK is a laser focus on digital, data and analytics on the reinvention of drug discovery.” Karenann Terrell, our Chief Digital and Technology Officer, speaking at #FTPharma on our approach to technology and digital transformation at GSK.
about 18 hours ago
-
GSK @GSK
Our CEO, Emma, speaking to @SarahNev at #FTPharma about the progress we have made in R&D, and setting the future direction of the company with the creation of a world-leading consumer healthcare business. Read more gsk.to/2Kaetr7 twitter.com/ftlive/status/…
about 1 day ago
-
GSK @GSK
Revealing the beautiful complexity of the immune system: David Roth works in immunology research and development. Click below to go #BehindTheScience as he explains how we’re working to unlock the secrets of the body’s immune system #ACR2019
about 2 days ago
